The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
The cognitive impact of antiepileptic drugs
Open accessAbstract
Effective treatment of epilepsy depends on medication compliance across a lifetime, and studies indicate that drug tolerability is a significant limiting factor in medication maintenance. Available antiepileptic drugs (AEDs) have the potential to exert detrimental effects on cognitive function and therefore compromise patient wellbeing. On the other hand, some agents may serve to enhance cognitive function. In this review paper, we highlight the range of effects on cognition linked to a variety of newer and older AEDs, encompassing key alterations in both specific executive abilities and broader neuropsychological functions. Importantly, the data reviewed suggest that the effects exerted by an AED could vary depending on both patient characteristics and drug-related variables. However, there are considerable difficulties in evaluating the available evidence. Many studies have failed to investigate the influence of patient and treatment variables on cognitive functioning. Other difficulties include variation across studies in relation to design, treatment group and assessment tools, poor reporting of methodology and poor specification of the cognitive abilities assessed. Focused and rigorous experimental designs including a range of cognitive measures assessing more precisely defined abilities are needed to fill the gaps in our knowledge and follow up reported patterns in the literature. Longitudinal studies are needed to improve our understanding of the influence of factors such as age, tolerance and the stability of cognitive effects. Future trials comparing the effects of commonly prescribed agents across patient subgroups will offer critical insight into the role of patient characteristics in determining the cognitive impact of particular AEDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
Glauser, T. A., Cnaan, A., Shinnar, S., Hirtz, D. G., Dlugos, D., Masur, D., Clark, P. O., Capparelli, E. V., & Adamson, P. C. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902014 · Cited by 645
Phenobarbital for Febrile Seizures — Effects on Intelligence and on Seizure Recurrence
Farwell, J. R., Lee, Y. J., Hirtz, D. G., Sulzbacher, S. I., Ellenberg, J. H., & Nelson, K. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220604 · Cited by 561
Outcomes of Add‐on Treatment with Lamotrigine in Partial Epilepsy
Smith, D., Baker, G., Davies, G., Dewey, M., & Chadwick, D. W. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02417.x · Cited by 330
Vining, E. P. G., Mellits, E. D., Dorsen, M. M., Cataldo, M. F., Quaskey, S. A., Spielberg, S. P., & Freeman, J. M. (1987) · Pediatrics · doi:10.1542/peds.80.2.165 · Cited by 270
Effects of topiramate on cognitive function
Thompson, P. J. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.69.5.636 · Cited by 257
Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures
French, J. A., Kugler, A. R., Robbins, J. L., Knapp, L. E., & Garofalo, E. A. (2003) · Neurology · doi:10.1212/01.wnl.0000068024.20285.65 · Cited by 239
Side effects of phenobarbital in toddlers; behavioral and cognitive aspects
Camfield, C. S., Chaplin, S., Doyle, A.-B., Shapiro, S. H., Cummings, C., & Camfield, P. R. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80507-7 · Cited by 231
Smith, D. B., Mattson, R. H., Cramer, J. A., Collins, J. F., Novelly, R. A., Craft, B., & Veterans Administration Epilepsy Cooperative Study Group (1987) · Epilepsia · doi:10.1111/j.1528-1157.1987.tb05778.x · Cited by 224
Aldenkamp, A. P., Baker, G., Mulder, O. G., Chadwick, D., Cooper, P., Doelman, J., Duncan, R., Gassmann‐Mayer, C., de Haan, G. J., Hughson, C., et al. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00322.x · Cited by 197
Kälviäinen, R. (1995) · Archives of Neurology · doi:10.1001/archneur.1995.00540340081016 · Cited by 174
Cited by
Cognitive Impairment in People with Epilepsy
Novak, A., Vizjak, K., & Rakusa, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11010267 · Cited by 267
Fu, C.-H., Iascone, D. M., Petrof, I., Hazra, A., Zhang, X., Pyfer, M. S., Tosi, U., Corbett, B. F., Cai, J., Lee, J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.101 · Cited by 107
Nabbout, R., Auvin, S., Chiron, C., Irwin, J., Mistry, A., Bonner, N., Williamson, N., & Bennett, B. (2018) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.08.029 · Cited by 80
Fukuyama, K., & Okada, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094473 · Cited by 22
Foley, P., Kong, Y., Dirvanskiene, R., valdes-Hernandez, M., Bastiani, M., Murnane, J., Sellar, R., Roberts, N., Pernet, C., Weir, C., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac124 · Cited by 11
Metadata
- Authors
- Eddy, C. M., Rickards, H. E., & Cavanna, A. E.
- Venue
- Therapeutic Advances in Neurological Disorders
- Publisher
- SAGE Publications
- Published
- 2011-09-13
- Volume
- 4
- Issue
- 6
- Pages
- 385-407
- ISSN
- 1756-2856 (ISSN-L)
- 1756-2864
- OpenAlex
- W2019178697
- Cited by
- 404
- References
- 77
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The cognitive impact of antiepileptic drugs. https://app.cochat.ai/papers/10.1177/1756285611417920
- The paper
- Eddy, C. M., Rickards, H. E., & Cavanna, A. E. (2011). The cognitive impact of antiepileptic drugs. Therapeutic Advances in Neurological Disorders. https://doi.org/10.1177/1756285611417920
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.